Sanofi CEO Paul Hudson Replaced by Belén Garijo Amid Company Challenges
Sanofi replaces CEO Paul Hudson with Belén Garijo amid slow R&D recovery and strategic shifts, appointing an interim CEO until Garijo's April start.
Sanofi replaces CEO Paul Hudson with Belén Garijo amid slow R&D recovery and strategic shifts, appointing an interim CEO until Garijo's April start.
France's economy is forecasted to grow moderately in 2026 alongside a cautious financial outlook for the pharmacy sector, with calls for increased state support to sustain pharmacy businesses.
BNP Paribas deepens its engagement in circular economy with strategic funding for Le Drive tout nu, expanding zero-waste consumption in France.
France increases Doliprane production by 30% with major investments announced at the Choose France summit, underscoring a broader push for domestic manufacturing growth.